Internal Medicine, Gastroenterology · Huntsville, AL
NPI
1497947949
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
119 Longwood Dr SW
Huntsville, AL, 35801
Phone (256) 533-6488
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
2,896 services
Medicare patients, 2024
570
Average age 73
Drug cost, 2024
$1.2M
2,537 prescriptions
Company payments, 2025
$3,070
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meredith C Roath was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,285 times for 16 patients. In total Meredith C Roath billed 2,896 services in 38 codes, and Medicare paid $119K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,285 | 16 | $0.11 | $136 |
| 88305 Surgical Pathology Examination | Office | 326 | 132 | $23.43 | $7,638 |
| 99214 Office E&M - Established | Office | 324 | 251 | $79.11 | $26K |
| 43239 Upper GI Endoscopy | Facility | 143 | 140 | $60.52 | $8,654 |
| 88313 Surgical Pathology Examination | Office | 142 | 67 | $46.80 | $6,645 |
| 45380 Lower GI Endoscopy - Other | Facility | 89 | 89 | $89.18 | $7,937 |
| 99213 Office E&M - Established | Office | 83 | 79 | $58.16 | $4,827 |
| 88312 Surgical Pathology Examination | Office | 79 | 57 | $57.54 | $4,545 |
| 99204 Office E&M - New | Office | 77 | 77 | $111.90 | $8,616 |
| 45385 Colonoscopy - Lesion Removal | Facility | 67 | 66 | $185.20 | $12K |
| 43248 Upper GI Endoscopy | Facility | 41 | 40 | $112.06 | $4,595 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 17 | $57.47 | $2,012 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 35 | 27 | $71.37 | $2,498 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 30 | 30 | $160.91 | $4,827 |
| 99203 Office E&M - New | Office | 16 | 16 | $73.53 | $1,176 |
By year: 2022 $189K for 7,176 services; 2023 $181K for 6,910 services; 2024 $119K for 2,896 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 326 | 132 | $23.43 | $7,638 |
| 88313 Surgical Pathology Examination | 142 | 67 | $46.80 | $6,645 |
| 88312 Surgical Pathology Examination | 79 | 57 | $57.54 | $4,545 |
Medicare prescription drug claims, 2024
In 2024, the drug Meredith C Roath prescribed most often to Medicare patients was Pantoprazole Sodium, with 452 prescriptions and refills. In total Meredith C Roath wrote 2,537 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 452 | 979 | 179 | $5,229 |
| Famotidine Generic | 263 | 564 | 94 | $2,511 |
| Omeprazole Generic | 182 | 433 | 74 | $2,835 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 132 | 132 | 131 | $8,322 |
| Linzess Linaclotide | 125 | 184 | 33 | $95K |
| Lansoprazole Generic | 120 | 220 | 47 | $4,539 |
| Esomeprazole Magnesium Generic | 94 | 194 | 29 | $9,245 |
| Dicyclomine Hcl Generic | 94 | 146 | 34 | $2,139 |
| Creon Lipase/Protease/Amylase | 81 | 106 | 25 | $268K |
| Rabeprazole Sodium Generic | 64 | 122 | 22 | $4,519 |
| Cholestyramine Cholestyramine (With Sugar) | 56 | 84 | 27 | $6,320 |
| Lubiprostone Generic | 53 | 81 | 25 | $8,633 |
| Ondansetron Odt Ondansetron | 43 | 51 | 27 | $837 |
| Metoclopramide Hcl Generic | 38 | 58 | 11 | $89.13 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 37 | 37 | 33 | $804 |
Brand drugs: 554 claims; generic drugs: 1,983 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meredith C Roath $3,070 ($3,070 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $922.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 45 | $922 |
| Madrigal Pharmaceuticals MDGL | 10 | $406 |
| Janssen Biotech, Inc. JNJ | 22 | $371 |
| Phathom Pharmaceuticals, Inc. PHAT | 15 | $355 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $186 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $167 |
| QOL Medical, LLC | 5 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $80.89 |
| Genzyme Corporation SNY | 3 | $77.38 |
| Gilead Sciences, Inc. GILD | 4 | $75.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.